ARTICLE | Company News
Echelon Research Laboratories Inc other research news
June 19, 2000 7:00 AM UTC
Echelon received $500,000 Phase II SBIR grant from the National Institute of Diabetes and Digestive and Kidney Diseases to develop fluorescently labeled isoprenoids for use in developing cancer therap...